Efficacy of Biological Therapy in Pediatric Inflammatory Bowel Disease
NCT06742606
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Effect of Drug
Interventions
BIOLOGICAL:
Group 1 of patients will receive Adalimumab while Group 1 will receive ustekinumab
Sponsor
Ain Shams University